Literature DB >> 27854507

Sex-Based Genetic Association Study Identifies CELSR1 as a Possible Chronic Obstructive Pulmonary Disease Risk Locus among Women.

Megan Hardin1,2, Michael H Cho1,2, Sunita Sharma3, Kimberly Glass1, Peter J Castaldi1, Merry-Lynn McDonald1, Hugues Aschard4, Jody Senter-Sylvia1, Kelan Tantisira1,2, Scott T Weiss1,2, Craig P Hersh1,2, Jarrett D Morrow1,2, David Lomas5, Alvar Agusti6, Per Bakke7, Amund Gulsvik8, George T O'Connor9, Josée Dupuis10,11, John Hokanson12, James D Crapo13, Terri H Beaty14, Nan Laird4, Edwin K Silverman1,2, Dawn L DeMeo1,2.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a complex disease with strong environmental and genetic influences and sexually dimorphic features. Although genetic risk factors for COPD have been identified, much of the heritability remains unexplained. Sex-based genetic association studies may uncover additional COPD genetic risk factors. We studied current and former smokers from COPD case-control cohorts (COPDGene non-Hispanic whites and African Americans, Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-Points, and Genetics of Chronic Obstructive Lung Disease). COPD was defined as post-bronchodilator forced expiratory volume in 1 second/forced vital capacity less than 0.70 and forced expiratory volume in 1 second percent predicted less than 80. Testing was performed across all cohorts and combined in a meta-analysis adjusted for age, pack-years, and genetic ancestry. We first performed genome-wide single-nucleotide polymorphism (SNP)-by-sex interaction testing on the outcome of COPD affection status. We performed sex-stratified association testing for SNPs with interaction P less than 10-6. We examined over 8 million SNPs in four populations, including 6,260 subjects with COPD (40.6% female) and 5,269 smoking control subjects (47.3% female). The SNP rs9615358 in the cadherin gene CELSR1 approached genome-wide significance for an interaction with sex (P = 1.24 × 10-7). In the sex-stratified meta-analysis, this SNP was associated with COPD among females (odds ratio, 1.37 [95% confidence interval, 1.25-1.49]; P = 3.32 × 10-7) but not males (odds ratio, 0.90 [95% confidence interval, 0.79-1.01]; P = 0.06). CELSR1 is involved in fetal lung development. In a human fetal lung tissue dataset, we observed greater CELSR1 expression in female compared with male samples. This SNP-by-sex genome-wide association analysis identified the fetal lung development gene, CELSR1, as a potential sex-specific risk factor for COPD. Identifying sex-specific genetic risk factors may reveal new insights into sexually dimorphic features of COPD.

Entities:  

Keywords:  chronic obstructive pulmonary disease; genetics; genome-wide association study; growth and development; sex

Mesh:

Substances:

Year:  2017        PMID: 27854507      PMCID: PMC5359539          DOI: 10.1165/rcmb.2016-0172OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  40 in total

1.  Heritability estimation of sex-specific effects on human quantitative traits.

Authors:  Lin Pan; Carole Ober; Mark Abney
Journal:  Genet Epidemiol       Date:  2007-05       Impact factor: 2.135

2.  SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap.

Authors:  Andrew D Johnson; Robert E Handsaker; Sara L Pulit; Marcia M Nizzari; Christopher J O'Donnell; Paul I W de Bakker
Journal:  Bioinformatics       Date:  2008-10-30       Impact factor: 6.937

3.  Proteomics. Tissue-based map of the human proteome.

Authors:  Mathias Uhlén; Linn Fagerberg; Björn M Hallström; Cecilia Lindskog; Per Oksvold; Adil Mardinoglu; Åsa Sivertsson; Caroline Kampf; Evelina Sjöstedt; Anna Asplund; IngMarie Olsson; Karolina Edlund; Emma Lundberg; Sanjay Navani; Cristina Al-Khalili Szigyarto; Jacob Odeberg; Dijana Djureinovic; Jenny Ottosson Takanen; Sophia Hober; Tove Alm; Per-Henrik Edqvist; Holger Berling; Hanna Tegel; Jan Mulder; Johan Rockberg; Peter Nilsson; Jochen M Schwenk; Marica Hamsten; Kalle von Feilitzen; Mattias Forsberg; Lukas Persson; Fredric Johansson; Martin Zwahlen; Gunnar von Heijne; Jens Nielsen; Fredrik Pontén
Journal:  Science       Date:  2015-01-23       Impact factor: 47.728

4.  Gender differences in COPD: are women more susceptible to smoking effects than men?

Authors:  Inga-Cecilie Sørheim; Ane Johannessen; Amund Gulsvik; Per S Bakke; Edwin K Silverman; Dawn L DeMeo
Journal:  Thorax       Date:  2010-06       Impact factor: 9.139

5.  Sex differences in severe pulmonary emphysema.

Authors:  Fernando J Martinez; Jeffrey L Curtis; Frank Sciurba; Jeanette Mumford; Nicholas D Giardino; Gail Weinmann; Ella Kazerooni; Susan Murray; Gerard J Criner; Donald D Sin; James Hogg; Andrew L Ries; MeiLan Han; Alfred P Fishman; Barry Make; Eric A Hoffman; Zab Mohsenifar; Robert Wise
Journal:  Am J Respir Crit Care Med       Date:  2007-04-12       Impact factor: 21.405

6.  Claims of sex differences: an empirical assessment in genetic associations.

Authors:  Nikolaos A Patsopoulos; Athina Tatsioni; John P A Ioannidis
Journal:  JAMA       Date:  2007-08-22       Impact factor: 56.272

7.  A role for Wnt signaling genes in the pathogenesis of impaired lung function in asthma.

Authors:  Sunita Sharma; Kelan Tantisira; Vincent Carey; Amy J Murphy; Jessica Lasky-Su; Juan C Celedón; Ross Lazarus; Barbara Klanderman; Angela Rogers; Manuel Soto-Quirós; Lydiana Avila; Thomas Mariani; Roger Gaedigk; Stephen Leeder; John Torday; David Warburton; Benjamin Raby; Scott T Weiss
Journal:  Am J Respir Crit Care Med       Date:  2009-11-19       Impact factor: 21.405

8.  Sex-specific features of emphysema among current and former smokers with COPD.

Authors:  Megan Hardin; Marilyn Foreman; Mark T Dransfield; Nadia Hansel; MeiLan K Han; Michael H Cho; Surya P Bhatt; Joe Ramsdell; David Lynch; Jeffrey L Curtis; Edwin K Silverman; George Washko; Dawn DeMeo
Journal:  Eur Respir J       Date:  2015-11-05       Impact factor: 16.671

9.  A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13.

Authors:  Michael H Cho; Peter J Castaldi; Emily S Wan; Mateusz Siedlinski; Craig P Hersh; Dawn L Demeo; Blanca E Himes; Jody S Sylvia; Barbara J Klanderman; John P Ziniti; Christoph Lange; Augusto A Litonjua; David Sparrow; Elizabeth A Regan; Barry J Make; John E Hokanson; Tanda Murray; Jacqueline B Hetmanski; Sreekumar G Pillai; Xiangyang Kong; Wayne H Anderson; Ruth Tal-Singer; David A Lomas; Harvey O Coxson; Lisa D Edwards; William MacNee; Jørgen Vestbo; Julie C Yates; Alvar Agusti; Peter M A Calverley; Bartolome Celli; Courtney Crim; Stephen Rennard; Emiel Wouters; Per Bakke; Amund Gulsvik; James D Crapo; Terri H Beaty; Edwin K Silverman
Journal:  Hum Mol Genet       Date:  2011-11-11       Impact factor: 6.150

10.  Genetic control of gene expression at novel and established chronic obstructive pulmonary disease loci.

Authors:  Peter J Castaldi; Michael H Cho; Xiaobo Zhou; Weiliang Qiu; Michael Mcgeachie; Bartolome Celli; Per Bakke; Amund Gulsvik; David A Lomas; James D Crapo; Terri H Beaty; Stephen Rennard; Benjamin Harshfield; Christoph Lange; Dave Singh; Ruth Tal-Singer; John H Riley; John Quackenbush; Benjamin A Raby; Vincent J Carey; Edwin K Silverman; Craig P Hersh
Journal:  Hum Mol Genet       Date:  2014-10-14       Impact factor: 6.150

View more
  15 in total

1.  Update in Chronic Obstructive Pulmonary Disease 2017.

Authors:  William Z Zhang; Kazunori Gomi; Seyed Babak Mahjour; Fernando J Martinez; Renat Shaykhiev
Journal:  Am J Respir Crit Care Med       Date:  2018-06-15       Impact factor: 21.405

2.  HIV Infection, Pulmonary Tuberculosis, and COPD in Rural Uganda: A Cross-Sectional Study.

Authors:  Crystal M North; Joseph G Allen; Samson Okello; Ruth Sentongo; Bernard Kakuhikire; Edward T Ryan; Alexander C Tsai; David C Christiani; Mark J Siedner
Journal:  Lung       Date:  2017-12-19       Impact factor: 2.584

Review 3.  Genetic Advances in Chronic Obstructive Pulmonary Disease. Insights from COPDGene.

Authors:  Margaret F Ragland; Christopher J Benway; Sharon M Lutz; Russell P Bowler; Julian Hecker; John E Hokanson; James D Crapo; Peter J Castaldi; Dawn L DeMeo; Craig P Hersh; Brian D Hobbs; Christoph Lange; Terri H Beaty; Michael H Cho; Edwin K Silverman
Journal:  Am J Respir Crit Care Med       Date:  2019-09-15       Impact factor: 21.405

4.  Gene-Based Analysis Reveals Sex-Specific Genetic Risk Factors of COPD.

Authors:  Jaehyun Joo; Blanca Himes
Journal:  AMIA Annu Symp Proc       Date:  2022-02-21

Review 5.  Sex and Gender Omic Biomarkers in Men and Women With COPD: Considerations for Precision Medicine.

Authors:  Dawn L DeMeo
Journal:  Chest       Date:  2021-03-18       Impact factor: 10.262

Review 6.  Recent advances in chronic obstructive pulmonary disease pathogenesis: from disease mechanisms to precision medicine.

Authors:  Corry-Anke Brandsma; Maarten Van den Berge; Tillie-Louise Hackett; Guy Brusselle; Wim Timens
Journal:  J Pathol       Date:  2019-12-03       Impact factor: 7.996

7.  Women manifest more severe COPD symptoms across the life course.

Authors:  Dawn L DeMeo; Sreeram Ramagopalan; Abhishek Kavati; Ashok Vegesna; Meilan K Han; Anthony Yadao; Teresa K Wilcox; Barry J Make
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-10-01

8.  Gene expression profile of human lung in a relatively early stage of COPD with emphysema.

Authors:  Ina Jeong; Jae-Hyun Lim; Dong Kyu Oh; Woo Jin Kim; Yeon-Mok Oh
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-08-28

Review 9.  Noncanonical Wnt planar cell polarity signaling in lung development and disease.

Authors:  Eszter K Vladar; Melanie Königshoff
Journal:  Biochem Soc Trans       Date:  2020-02-28       Impact factor: 5.407

10.  Bayesian reassessment of the epigenetic architecture of complex traits.

Authors:  Daniel Trejo Banos; Daniel L McCartney; Marion Patxot; Lucas Anchieri; Thomas Battram; Colette Christiansen; Ricardo Costeira; Rosie M Walker; Stewart W Morris; Archie Campbell; Qian Zhang; David J Porteous; Allan F McRae; Naomi R Wray; Peter M Visscher; Chris S Haley; Kathryn L Evans; Ian J Deary; Andrew M McIntosh; Gibran Hemani; Jordana T Bell; Riccardo E Marioni; Matthew R Robinson
Journal:  Nat Commun       Date:  2020-06-08       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.